Brighton Jones’s Summit Therapeutics SMMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$207K Buy
+12,240
New +$183K ﹤0.01% 1256

Other funds holding SMMT

Brighton Jones's SMMT Position: Q3 2026 in Review

Brighton Jones opened a new position in Summit Therapeutics (SMMT) in Q3 2026: 12,240 shares worth $207K. The stake represents ﹤0.01% of the portfolio and ranks #1256 among its holdings.

295 funds tracked by Wall St. Rank hold SMMT as of Q3 2026.

  • Brighton Jones held 12,240 shares of Summit Therapeutics worth $207K as of Q3 2026.
  • Summit Therapeutics was a new Brighton Jones position in Q3 2026.
  • Summit Therapeutics made up ﹤0.01% of Brighton Jones's portfolio in Q3 2026, its #1256 holding.
  • 295 funds tracked by Wall St. Rank held Summit Therapeutics as of Q3 2026.

Based on Brighton Jones's 13F filing for Q3 2026, filed 3 Nov 2026.